Novanta Inc. (NASDAQ:NOVT – Get Free Report) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $143.00 and last traded at $143.82, with a volume of 7057 shares. The stock had previously closed at $146.53.
Analyst Ratings Changes
Separately, Robert W. Baird cut their price target on shares of Novanta from $175.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, November 6th.
Get Our Latest Analysis on Novanta
Novanta Stock Down 0.9 %
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Empowered Funds LLC acquired a new position in Novanta during the fourth quarter worth about $26,000. GAMMA Investing LLC grew its position in Novanta by 33.1% during the third quarter. GAMMA Investing LLC now owns 237 shares of the technology company’s stock worth $42,000 after buying an additional 59 shares during the period. GHP Investment Advisors Inc. acquired a new position in Novanta during the third quarter worth about $49,000. nVerses Capital LLC acquired a new position in Novanta during the third quarter worth about $54,000. Finally, Huntington National Bank grew its position in Novanta by 53.6% during the fourth quarter. Huntington National Bank now owns 430 shares of the technology company’s stock worth $66,000 after buying an additional 150 shares during the period. 98.35% of the stock is currently owned by institutional investors and hedge funds.
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
See Also
- Five stocks we like better than Novanta
- How is Compound Interest Calculated?
- Vertiv Stock Under Pressure: Is Opportunity Knocking?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MicroStrategy’s 8% Preferred Stock: What Investors Should Know
- Pros And Cons Of Monthly Dividend Stocks
- Biotechs on the Brink: 2 Stocks With Huge Potential
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.